Staphylococcus aureus may cause serious infections and is one of the most lethal and common causes of sepsis. TLR2 has been described as the main pattern recognition receptor (PRR) which senses SA and elicits production of pro-inflammatory cytokines via MyD88-NF-κB signaling. SA can also induce the production of IFNβ, a cytokine that requires interferon regulatory factors (IRFs) for its transcription, but the signaling mechanism for IFN induction by SA are unclear. Surprisingly, we demonstrate that activation of TLR2 by lipoproteins does not contribute to IFN production but instead can suppress the induction of IFNβ in human primary monocytes and monocyte-derived macrophages (MDMs). The production of IFNβ was induced by TLR8-mediated sensing of SA RNA which triggered IRF5 nuclear accumulation, and this could be antagonized by concomitant TLR2 signaling. The TLR8-mediated activation of IRF5 was dependent on TAK1 and IKKβ, which thus reveals a physiological role of the recently described IRF5-activating function of IKK. TLR8-IRF5 signaling was necessary for induction of IFN and IL12 by SA, and it also contributed to the induction of TNF. In conclusion, our study demonstrates a physiological role of TLR8 in the sensing of entire SA in human primary phagocytes, including the induction of IFNβ and IL12 production via a TAK1-IKKβ-IRF5 pathway that can be inhibited by TLR2 signaling.
Staphylococcus aureus; STING, stimulator of interferon genes; TAK1, transforming growth factor -activated kinase 1; TBK1, TANK-binding kinase 1; wt, wild-type.
Introduction
Staphylococcus aureus (SA) can act as a peaceful colonizer of the skin and the nostrils or as an aggressive pathogen causing invasive diseases and sepsis. Intracellular survival of SA, abscess formation, as well as the emergence of methicillin resistant strains complicate the treatment of serious infections (1) . SA also produces virulence factors such as hemolytic and leucolytic toxins and C-targeting factors which contribute to immune evasion (2) . TLR2 is a primary PRR for sensing of SA by immune cells and mediates resistance of mice against experimental SA infection (3). SA deficient in lipoprotein synthesis (Δlgt) does not activate TLR2 and elicit reduced pro-inflammatory responses in human cell lines (4) . Children and teenagers with MyD88-or IL1R-associated kinase 4-deficiency are at risk of infections with pyogenic bacteria, in particular SA, Streptococcus pneumonia, and Pseudomonas aeruginosa , while their resistance against infection with other pathogens is normal (5, 6) . This indicates a particular importance of TLR2 and/or IL1Rs for resistance against SA infection in young humans.
Type I IFNs are classical antiviral cytokines, but they are also induced by intracellular and extracellular bacteria. The impact of the main Type I IFNs (IFNα and IFNβ) on bacterial infections is less clear and spans from enhanced innate and cell-mediated immunity to immune suppression and dysregulation which may contribute to the progression of septic shock (7) . The predominant pathway of IFNβ induction by Gram negative bacteria is by LPSmediated activation of endosomal TLR4 signaling via the TIR-domain containing adapter inducing IFN-IRF3 pathway (8, 9) . For Gram-positive bacteria there may not be a single predominant mechanism for IFNβ induction as multiple pathogen-associated molecular patterns (PAMPS) and cell host receptors have been implicated in different model systems. In murine phagocytes recognition of bacterial RNA and DNA appears as central for IFN production (10) (11) (12) , and mouse TLR13 was recently identified as a sensor of RNA of microbial origin (13, 14) . Induction of type I IFNs by SA has been examined in different human and murine cell types with different conclusions regarding the molecular mechanisms involved. SA PAMPs suggested to be responsible for IFN induction include staphylococcal protein A (SpA), DNA, RNA, and lipoteichoic acid, and TLR2, TLR7, TLR9, and cytosolic PRRs were implicated (15) (16) (17) (18) (19) (20) (21) (22) .
The aim of the present study was to examine the role of TLR2 and other PRRs for SAinduced IFNβ production in human primary monocytes and MDMs. Unexpectedly we found that TLR2 activation could suppress the SA-induced production of IFNβ. In contrast, induction of IFNβ was triggered by SA RNA which activated a TLR8-IRF5 signaling axis in a TAK1 and IKKβ dependent fashion. We here establish TLR8 as a second MyD88 dependent PRR of SA in human primary monocytes and MDMs and show that it is essential for the induction of IFNβ production by whole bacteria via a recently identified IKK-IRF5 activation pathway. We also demonstrate a cross-regulatory function of TLR2 in TLR8-IRF5 signaling.
Materials and Methods

Materials
Concentrations of IFNβ were determined with the VeriKine-HS TM Human Human InterferonBeta Serum ELISA Kit (PBL Assay Science, Piscataway, NJ) typically with no dilution or 1:2 dilutions of the culture supernatants. BioPlex assays were from BioRad and were analyzed as per the manufacturer with dilutions of the supernatants ranging from none to 200, depending on the cytokine to be examined. E. coli bioparticles was of the rough K12-strain (Invitrogen).
The following TLR-ligands were from Invivogen: LPS from the E. coli K12-strain, FSL-1, Pam3Cys, R837, CL75, polyriboinosinic polyribocytidylic acid (pI:C), and polyuridylic acid (pU). Lipofectamine 2000 (L2K) was from Invitrogen, while poly-L-arginine (pL-Arg) was from Sigma-Aldrich. RNAse A was from Qiagen. The IKKβ-inhibitor BI605906 was generously provided by prof. Sir Philip Cohen (University of Dundee, Scotland), while IKKII-VIII and the TAK1 inhibitor 5z-7-oxozeanol was from Calbiochem/MerckMillipore (Darmstadt, Germany). The TAK1 inhibitor NG-25 was from MedChem Express (Monmouth Junction, NJ).
Bacteria and bacterial lysates
Staphylococcus aureus 113-wild type strain, its isogenic 113Δlgt mutant, and the pRBlgtreconstituted 113Δlgt strain were generously provided by prof. Friedrich Göetz (University of Tübingen, Germany). The Newman and Cowan strains were generously provided by prof.
Timothy Foster (Trinity College, Ireland), while the Wood-46 strain was from ATCC (10832).
The bacteria were grown on tryptic-soy agar (TSA) plates which were supplemented with 10ug/ml erythromycin or Kanamycin for the Δlgt mutant or the pRBlgt reconstituted strains, respectively. For preparation of bacteria colonies were picked and grown in 5ml tryptic-soy broth during vigorously shaking at 37ºC overnight (12-18hrs) for use in infection experiments. To prepare heat killed bacteria a pre-culture was diluted 1:100-200 in 50-100ml tryptic-soy broth in 500-1000ml culture flasks and grown in a shaking-incubator to the exponential phase (approx. 4hrs), stationary phase (approx. 12hrs), or decline phase (20-24hrs), as appropriate. For heat killing of the bacteria was spun down, re-suspended in PBS, incubated at 80ºC for 30 minutes, and finally washed one time with PBS. For quantification of bacteria by OD-measurements a standard curve was generated with serial dilutions of heat killed (HK) bacteria that had been quantified by manual counting in a Bürker chamber.
Fluorescent labelling of the HK bacteria was done using Alexa 488-succinimidyl-ester (SE) (Invitrogen). This reagent was dissolved in DMSO and immediately added to a solution of 2x10 10 SA/ml in NaHCO3 (167uM, pH8.3) yielding a final concentration of 1mg/ml dye.
Incubation with agitation was done for 1hr at RT, and the labelled bacteria were washed two times with 500ul PBS and counted. Preparation of crude bacterial lysate was done by a previous described protocol (4) with some modifications. Glass particles (0.1mm, Sigma)
were pre-heated at 200ºC for 4 hours to eliminate potential TLR-ligand contaminants. The particles were added to 2x10 10 SA113Δlgt (HK, exponential growth phase) in ice-cold PBS and run in four cycles on a Precellys 24 bead-beater (Bertin Technology, France) with chilling on ice between each cycle. The glass particles and intact bacteria were spun down and the crude lysate supernatants were added to new tubes for storage at -80ºC.
Blood, monocytes, and stimulation/infection
Fresh blood, serum, and buffycoats were acquired from healthy volunteers under informed written consent approved by the Regional Committee for Medical and Health Research Ethics (REC Central, Norway, #2009/2245). Human PBMC were isolated from buffycoats using Lymphoprep (Axis-Shield) as described by the manufacturer and monocytes were purified by adherence in culture plates and maintained in RPMI1640 (Gibco) supplemented with 10% pooled human serum. TLR2 blocking was done by 30 minutes pre-treatment with the antimouse/human TLR2 mAb clone T2.5 (#HM1054, Hycult Biotech) at 5ug/ml and mouse IgG1 mAb (R&D) served as isotype control. pI:C, pU, and crude SA lysate, with or without RNAse A (Qiagen) treatment (2ul/ml, 1hr at 37 ºC), was pre-complexed with pL-Arg at a 1:1 ratio (w/w) in Opti-MEM (Invitrogen), or with 2.5ul L2K/ug RNA in Opti-MEM for transfection.
For infection of monocytes and macrophages live bacteria from overnight cultures with or without the bacterial culture media were diluted in RPMI and incubated for 1hr at RT before addition to the cells. Extracellular bacteria were killed after 1hr by addition of gentamycin to 100ug/ml. For Q-PCR analysis the cells were lysed after a total infection time of 3 to 4 hours, while cell culture supernatants were harvested after 5 to 6 hours of infection. 
Macrophages, siRNA, and Q-PCR
Whole blood model and flow cytometry analyses
The whole blood experiments were performed basically as described (23 
Western blot
Cells were adhered in 6-well plates, treated and lysed in 150ul lysisbuffer (20mM Tris-HCl, 1mM EDTA, 1mM EGTA, 137mM NaCl, 1% Triton X-100, 1mM sodium deoxycholate, 10% glycerol, 1mM Na3VO4, 50mM NaF and Complete protease inhibitor (Roche)). PAGE 
Immunofluorescence and Scan^R analyses
Immunofluorescence labelling was done as described (9) suppressed IL12p70 secretion to a similar degree as IFNβ, suggesting that these two cytokines share a regulatory mechanism (Fig. S1 ).
TLR2 ligands antagonize the induction of IFN by SA in human blood monocytes and whole blood. To simplify our model system we examined whether the defined synthetic TLR2/6 ligand FSL-1 alone would antagonize IFN-induction by HK SA Δlgt, E. coli and E.
coli LPS (Fig. 2A) . TLR2 co-stimulation with FSL-1 suppressed IFN induction by HK SA, but not HK E. coli and E. coli LPS. This confirmed that TLR2 activation blocks SA-induced IFNβ production, while it does not affect TLR4-TRIF signaling. Since SA lipopeptides can be both diacylated and triacylated (25) , and synthetic triacylated TLR1/2 ligand Pam3Cys which also inhibited the IFN induction by HK SA in monocytes (not shown).
We further examined the impact of the timing of TLR2 ligand administration relative to SA and found that maximum inhibition of IFN-induction was achieved when FSL-1 was added before or at the same time as the bacteria, while the inhibitory effect was gradually reduced if FSL-1 was added 15, 30, and 60 minutes later (Fig. 2B) . Thus, the TLR2-inhibitory effect is limited to an early time-frame of SA sensing by monocytes.
To examine if the inhibitory effect of TLR2 also is important in the more complex physiological environment of blood monocytes, we employed a lepirudin anti-coagulated human whole blood model (ex vivo) which enables crosstalk between all blood cells and most of the plasma cascades, including a C system that is functionally active under physiological conditions (23) . TLR2 co-stimulation fully suppressed SA-induced IFNβ production in whole blood (Fig. 2C ) confirming the validity of our PBMC-based model. Cytokine induction by HK SA is to a large extent dependent on phagocytosis and bacterial degradation (20, 26) . The TLR2 effect could thus possibly be explained by inhibition of phagocytosis. However, we found that TLR2 co-stimulation did not inhibit phagocytosis, but instead significantly increased the uptake of HK SA by monocytes in whole blood (Fig. 2E) . The mechanism for the enhanced phagocytosis is likely TLR2-mediated activation of the CR3 (CD11b/CD18), as SA phagocytosis in the whole blood model is strongly C dependent (27) and the CD11b level on both monocytes and granulocytes increased strongly upon TLR2 stimulation (Fig. 2F ).
SA RNA is an endosomal PRR ligand. As bacterial nucleic acids are implicated in type I
IFN induction in various model systems, we examined the importance of RNA in crude lysate of the HK SA Δlgt strain. Bacteria were mechanically disrupted, treated with RNAse A which cleaves single-stranded RNA, and the lysate mixed with poly-L-Arginine (pL-Arg) for delivery of nucleic acid to the monocyte endosomal compartment (28) (Fig. 3) . RNAsetreatment eliminated the induction of IFNβ, IL12p40, and IL12p70, and strongly reduced the release of IL1α, IL1β, and IL18. In contrast the levels of IL6 and IL8 were not affected by RNAse A (Fig. 3 ). This demonstrates that in lysate of HK SA deprived of TLR2 ligands ssRNA was a dominant PAMP for the induction of IFN, IL1, IL12, and IL18. Still, other PAMS distinct from RNA and lipoproteins were apparently dominating for IL6 and IL8
induction by these crude lysates.
TLR2 inhibits IFN and IL12 induction by both SA and TLR8 ligands. To clarify the mechanism of how SA RNA induces IFNβ in monocytes we compared the response by HK SA Δlgt with the synthetic TLR8-ligand polyuridylic acid (pU) and the dsRNA TLR3-ligand polyinosine:cytosine (pI:C). The RNA was delivered to the endosomal or the cytosolic compartment of monocytes by complexation with pL-Arg or transfection with lipofectamine (L2K), respectively, as previously shown (28) . Stimulation with SA, pU/pL-Arg, and pI:C/L2K induced IFNβ production, while stimulation with pI:C/pL-Arg and pU/L2K did not (Fig. 4A ). This implies that pU and pI:C induces IFNβ from the endosomal and the cytosolic compartments, respectively, and is consistent with high TLR8-and low TLR3-levels in monocytes (29) . Co-stimulation with FSL-1 strongly suppressed IFNβ induction by HK SA and pU, but not pI:C. TLR2 activation thus interferes with TLR8-signaling, but not cytosolic dsRNA-sensing or TLR4-TIR-domain containing adapter inducing IFN signaling ( Fig. 2A) .
Moreover, induction of IL12-p70 was solely induced by SA and pU in endosomes and was also inhibited by TLR2-activation (Fig. 4B) . GU-and U-rich ssRNA stimulate murine TLR7
and human TLR8 (30) , and the induction of IL12-p70 is a well-described characteristics of human TLR8 (28, 31) . Thus, the regulation of IFNβ and IL12-p70 production by monocytes is similar for SA and a defined TLR8-ligand, including its inhibition by TLR2-activation.
Additional correlative evidence for the involvement of TLR8 in the sensing of SA was found using the TLR8 specific imidazoquinoline agonist CL75, as CL75 mediated IFNβ induction was antagonized by TLR2 co-stimulation (Fig. 4C) . In contrast, IFNβ induction by the TLR7 specific ligand R837 was not antagonized by TLR2 co-stimulation (Fig. 4D ), arguing against a role of TLR7 in the IFNβ induction by SA. TLR8 immunofluorescence indicated that TLR8 was recruited to SA phagosomes (Fig. 4E ). Quantification using a high content screening system suggested that approximately 9% of the SA phagosomes stained positive for TLR8 one hour after exposure to bacteria (Fig. 4F) .
SA induces IFN via TLR8 and IRF5
The correlative data suggested that TLR8 was responsible for SA-induced IFN production.
Western blot analysis demonstrated that although SA and TLR2 ligands activated TBK1 phosphorylation, IRF3 was not activated (not shown). Furthermore, preliminary data suggested a possible involvement of IRF5. To clarify the mechanism we performed gene silencing of MDMs by transient transfection with siRNA targeting TLR7, TLR8, IRF5, and
Stimulator of interferon genes (STING). All targets were efficiently and specifically silenced on the mRNA level after sequential transfections (Fig. S2A) . Clear knockdown of TLR8 and IRF5 was also seen at the protein level (Fig. S2B) . However, two TLR8-bands of around 100kDa were not completely eliminated even several days after mRNA knockdown. These To further examine IRF5 activation we established a quantitative immunofluorescence method of transcription factor nuclear accumulation using high-content screening (Scan^R) (Fig. S3 ). Monocytes were stimulated with HK SA and TLR8 ligands and nuclear accumulation of total p65 (NF-kB/RelA), IRF3 (Fig. S3 ) and IRF5 (Fig. 6) was examined.
The level of nuclear IRF5 was low in resting cells (Fig. 6A ) and was strongly increased following pU/pL-Arg stimulation (Fig. 6B) and phagocytosis of HK SA Δlgt (Fig. 6D) . FSL-1 co-stimulation clearly reduced the nuclear accumulation of IRF5 induced by both stimuli ( Fig. 6C and 6E), which thus correlates with suppressed IFNβ and IL12 induction. Moreover, if SA was heat-inactivated during the stationary growth phase, the bacteria were markedly less potent as IFNβ inducers (not shown). The stationary phase SA did not induce IRF5 nuclear accumulation (Fig. 5F ), thus again demonstrating a correlation of SA-induced IFNβ production and IRF5 nuclear accumulation in monocytes. Around 25% of the monocytes that had phagocytosed HK SA Δlgt stained positive for nuclear IRF5 (Fig. 5G) . The frequency was strongly reduced by co-stimulation with FSL-1, as well as when HK SA from the stationary growth phase was used. Moreover, cells that did not phagocytosed bacteria -"SA bystanders" -did not have increased IRF5 nuclear accumulation. Thus, IRF5 nuclear accumulation was dependent on SA phagocytosis and not a result of paracrine signals.
Correlation of IRF5 translocation and phagocytosis was also seen in a whole-well overview with SA phagocytosis and IRF5 nuclear staining being strongest around the well center (not shown). pU/pL-Arg stimulation activated IRF5 nuclear accumulation to a similar degree as SA uptake, and was also suppressed by FSL-1 co-stimulation, while FSL-1 or LPS alone did not activate IRF5 (Fig. 5H ). In contrast, nuclear accumulation of p65 was seen with ligands for all three TLRs examined (Fig. 5I) . Only LPS activated IRF3 nuclear translocation (Fig. 5J) which is consistent with the IRF3 phosphorylation pattern (not shown). IRF1 was constitutively localized to the nuclei in monocytes, while IRF7 and IRF8 antibodies gave no specific staining (not shown). We conclude that SA induces IRF5 nuclear accumulation in monocytes as a consequence of TLR8 activation, and is blocked by TLR2 signaling.
TLR8-induced nuclear accumulation of IRF5 is dependent on TAK1 and IKKβ, while
nuclear accumulation of p65 is TAK1 independent. We further examined the requirement of central signaling components in the MyD88-pathway for TLR8-mediated IRF5 and p65 activation and TLR2-induced p65 activation. We quantified IRF5/p65 nuclear staining by two-color immunofluorescence (Fig. 7A-C) . We then used well-characterized chemical inhibitors of central signaling kinases to block monocyte signaling. To minimize possible problems of toxicity and secondary effects of the inhibitors we chose CL75 as TLR8 ligand, as CL75 elicits more rapid cytokine-induction than pU/pL-Arg and SA and thus limits the required incubation time with the inhibitors. Two structurally nonrelated inhibitors of TAK1
(5z-7-oxozeanol and NG-25) and IKKβ (IKKII-VIII and BI605906) were given as a 30 minute pre-treatment and their effects on TLR8-and TLR2-mediated nuclear accumulation of IRF5 and/or p65 were examined (Fig. 7D-F) . TLR8-induced IRF5 nuclear accumulation was dependent on both TAK1 and IKKβ (Fig. 7D) . In contrast, p65 nuclear accumulation following TLR8 and TLR2 stimulation was only dependent on IKKβ and not on TAK1 ( Fig.   7E and 7F).
Western blot analysis of mitogen-activated protein kinases (MAPKs) and other signaling intermediates was performed to verify the specificity of the inhibitors and to dissect further details of TLR2 and TLR8 signaling (Fig. S4 ). Both TAK1 inhibitors effectively blocked TLR2-and TLR8-induced JNK and p38 phosphorylation, in contrast to the IKKβ inhibitors. IKKβ inhibitors still blocked the phosphorylation of p105 and ERK1/2. This is in agreement with the canonical model of MyD88-signaling were JNK and p38 are downstream of TAK1, while activation of p105 and ERK1/2 are controlled by IKKβ (33) . The degradation of IkBα was not blocked by any of these inhibitors (Fig. S4) and IKKα can probably phosphorylate IkBα leading to its degradation once IKKβ is lost (34) . Failure of TAK1-inhibitors to rescue IkBα from degradation fits with the TAK1 independent nuclear accumulation of p65 ( Fig. 7E and F) , while p65 activation may require phosphorylation by IKKβ in addition to degradation of IkBα (33) . The TAK1 inhibitor 5z-7-oxozeanol efficiently antagonized IKKα/β phosphorylation and IKKβ activity (Fig. S4B) , while NG25 was less efficient (Fig. S4A) .
We further used gene silencing to examine the role of TLR7, TLR8, IRF5, IKK, STING, and TBK1 for IRF5 nuclear accumulation in MDMs upon infection with SA Δlgt (Fig. 7G) . Silencing show that also in MDMs SA activates IRF5 via TLR8 and IKK, confirming the specificity of IRF5 staining and the inhibitor data, while TLR7, TBK1, STING and p65 silencing did not influence IRF5 activation. In contrast, p65 nuclear accumulation was reduced solely with siRNA for p65, verifying the specificity of the nuclear translocation assay also for this factor (Fig. 7H) .
We conclude that both primary monocytes and MDMs sense SA via TLR8, and that TLR8-signaling includes a novel TAK1-IKKβ-IRF5 pathway which is required for IFNβ induction and which is blocked by TLR2 signaling. We thus propose a model for TLR8 and TLR2 signaling in monocytes that includes two distinct pathways (Fig. 8 ).
Discussion
We here provide evidence for a novel role of TLR8 in sensing of SA by human primary phagocytes. The physiological role of TLR8 is demonstrated by its contribution to the cytokine response induced by the whole bacteria during infection. While TLR2 and TLR8 display considerable redundancy in signaling and both contributed to SA-induced production of pro-inflammatory cytokines such as IL1/, IL18, and TNF, we show a specific role of TLR8 for the induction of IFN and IL12 via IRF5 activation. TLR8 and IRF5 also contributed to TNF-production. It is possible that IFNR-signaling could have influenced the TNF response, this seems less likely given the short incubation time (3hrs) used.
The function of human TLR8 as a sensor of bacterial RNA appears similar as murine TLR13 (13, 14) . However, while TLR13 detects a short sequence of bacterial 23S RNA with high specificity (14, 35) , TLR7 and TLR8 have weak sequence specificity and generally detects U-rich RNA (30) . Recently it was found that the natural TLR8 ligands are degradation products of U-rich RNA in the form of uridine and short U-containing oligomers that work synergistically (36) . In agreement with this model the commercial TLR13-ligand Sa19, which has a single U residue and is stabilized by thioester backbone, did not activate human monocytes or TLR8-expressing HEK293 cells (not shown). Thus, while human TLR8 and murine TLR13 may seem functionally analogous, their ligand specificities and mechanisms of activation are different.
The role of IFNβ in SA pathogenesis is controversial, and two recent studies found contradictory effects of IFNβ on the outcome of experimental murine infection (19, 20) . In humans SA forms abscesses with a high local bacterial load which can leak into the surrounding tissue and the blood stream. The maximum levels of IFNβ produced in response to HK SA exceeded that of HK E. coli and LPS. A more potent induction of IFN by HK SA from the exponential phase than the stationary phase may be related to the change in cell-wall thickness (37), or it could reflect changes in the amount of stimulatory RNA. Only a fraction (e.g. 20-30%) of the monocyte population stained positive for IRF5 and IRF3 nuclear accumulation after TLR8 or TLR4 activation, respectively. This fits with a stochastic model of IFNβ production in a cell population, which is explained by variations in limiting components at the cellular level (38, 39) . TLR8 is also a potent inducer of IL12 in human monocytes (28, 31) , while IRF5 regulates macrophage polarization and drives IL12 and IL23 production and T-helper-1 (Th1)-Th17 activation (40) . Th17-cells may also be important for protection from SA infections (41) . We found that lipoproteins of SA, either soluble or in the bacterial cell wall, activated TLR2 and strongly suppressed TLR8-induced production of IFNβ and IL12 by bacteria being degraded in phagosomes. This may represent a control mechanism to limit IFN and IL12 production induced by extracellular bacteria. It is thus possible that dysregulation of TLR2/TLR8 signaling can lead to disease progression, and it could represent a new immune-evasion target for bacteria such as SA.
Human blood monocytes also sense B. burgdorferi (Bb) RNA via TLR8 resulting in IFN production (42, 43) . While this finding is in agreement with our present study on SA, the proposed signaling mechanisms are different as they suggested IRF7 to be the central transcription factor involved. We show that TLR8-induced IFNβ production in monocytes and
MDMs is dependent on IRF5. The activation of IRF5 by SA and TLR8 ligands was rapid and did not occur in bystander cells not infected by SA, excluding the possibility that IRF5 is triggered via a secondary mediator. M. tuberculosis induces IFNβ in mouse macrophages through a NOD2-RIP2-TBK1-IRF5 pathway (44) . Also, a NOD2-IRF5 mechanism of SAmediated IFNβ induction in mouse BMDCs was recently reported (45) , and IRF5 was activated by TBK1/IKKi and RIP2 in overexpression studies (46, 47) . However, we found no induction of IFNβ in RNA-depleted SA lysates, which most likely contain significant amounts of peptidoglycan and bacterial cell-wall fragments. Moreover, silencing of TBK1 in MDMs did not affect IRF5 translocation in our studies. Thus, neither NOD2 nor TBK1 seems to be involved in SA-mediated IRF5 activation, arguing against a NOD2-RIP2-TBK1
pathway for SA-induced IFN in primary human phagocytes.
In model systems TLR7 and TLR8 can activate both IRF5 and IRF7, but not IRF3, and in THP-1 monocytic cells TLR7-induced IFNα is IRF5 dependent (47) . In human pDCs, IRF5 rather than IRF7 regulates TLR9-induced IFNβ production together with NF-κB p50 (48) . It thus appears that TLR7-, TLR8-, and TLR9-signaling can involve IRF5 in different The function of TAK1 is cell-type dependent (51) and was not necessary for p65/RelA nuclear accumulation in monocytes in our study. A TAK1 independent but MEKK3 dependent pathway of NF-κB activation has been described in mouse and human model systems (52, 53) and could possibly be involved also in human primary monocytes.
Monocytes have high mRNA levels of TLR2, TLR4 and TLR8, and low levels of TLR3, TLR7 and TLR9 (29) , which is generally in agreement with our data. Still, the TLR7-specific ligand (R837) induced IFNβ production in monocytes, suggesting that TLR7 is expressed at a functional level. The differential abilities of TLR8 and TLR2 to activate IRF5 via MyD88 might be related to their predominant localization within different cellular compartments -endosomal versus cell surface. TLR2 did not inhibit IFNβ induction via TLR4-, TLR7-or cytosolic pI:C which indicate a specificity for TLR8 signaling by TLR2 suppression. It is unclear whether the TLR2-induced feedback mechanism targets IRF5 directly, or if it acts upstream and interferes more generally with TLR8 signaling. Distinct signaling pathways activated by TLR2 that inhibition TLR8 signaling is a subject of future studies.
In conclusion, we have identified TLR8 as physiological significant sensor of entire The effect of silencing was tested by 1way RM ANOVA with Dunnett's Multiple Comparison Test compared to Ctrl siRNA. *p<0.05, **p<0.01, ***p<0.001. activates NF-kB p65 nuclear translocation in an IKKβ dependent fashion and is important for pro-inflammatory cytokine production. Both TLRs activate MAPKs by the TAK1 dependent pathway, but only TLR8 activate IRF5 nuclear translocation via a mechanism involving TAK1 and IKKβ. IRF5 nuclear accumulation via TLR8 signaling is a specific requirement for IFNβ and IL12 induction by SA, and also contributes to TNF production, while IL1 and IL18 are IRF5 independent. TLR2-activation inhibits TLR8-IRF5-signaling, probably at the level of TAK1/IKKβ or upstream. 
